Free Trial
LON:TCF

Theracryf (TCF) Share Price, News & Analysis

GBX 0.25 +0.02 (+6.38%)
As of 08/1/2025 11:04 AM Eastern

About Theracryf Stock (LON:TCF)

Key Stats

Today's Range
0.23
0.25
50-Day Range
0.22
0.28
52-Week Range
0.20
1.25
Volume
60.41 million shs
Average Volume
3.10 million shs
Market Capitalization
£1.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theracryf and its competitors with MarketBeat's FREE daily newsletter.

TCF Stock News Headlines

TheraCryf appoints new board member, issues options
Theracryf Plc (TCF.L)
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Theracryf PLC Share Chat (TCF)
See More Headlines

TCF Stock Analysis - Frequently Asked Questions

Theracryf's stock was trading at GBX 0.54 at the beginning of 2025. Since then, TCF shares have decreased by 53.5% and is now trading at GBX 0.25.

Theracryf Plc (LON:TCF) posted its quarterly earnings results on Tuesday, June, 3rd. The company reported ($0.36) EPS for the quarter. Theracryf had a negative net margin of 792.17% and a negative trailing twelve-month return on equity of 99.97%.

Shares of TCF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

Last Earnings
6/03/2025
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Banking
Current Symbol
LON:TCF
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (1.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£5.45 million
Net Margins
-792.17%
Pretax Margin
N/A
Return on Equity
-99.97%
Return on Assets
-48.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.20
Quick Ratio
N/A

Sales & Book Value

Annual Sales
£687.67 thousand
Price / Sales
1.74
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
GBX 0.85 per share
Price / Book
0.29

Miscellaneous

Outstanding Shares
477,357,778
Free Float
N/A
Market Cap
£1.19 million
Optionable
N/A
Beta
1.42
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (LON:TCF) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners